Profile: Becton Dickinson Infusion Therapy Systems, Inc. is a medical technology company that serves healthcare institutions, life science, researchers, clinical laboratories, industry and the general public. We manufacture and sell a broad range of medical supplies, devices, laboratory equipment and diagnostic products. Our ProbeTec™ ET System and the Viper™system offer DNA amplification assays for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) for use in public health, physician's office,and reference and hospital clinical laboratories. Our Bactec blood culture system is a fully automated microbiology growth and detection system designed to detect microbial growth from blood specimens. Our Directigen™ Flu A Test is an in vitro immunoassay membrane test for the direct rapid and qualitative detection of influenza A viral antigen from suitable specimens of symptomatic patients.We also and offer a complete line of centrifuges, blood bank accessories, loops, needles and unique miscellaneous laboratory products to meet the demands of both clinical and industrial laboratories.

The company has revenues of USD 5-10 Million, has ~900 employees. NYSE:BDX (SEC Filings)

FDA Registration Number: 1710034